Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Heroin Dependence
Interventions
DRUG

Intranasal challenge drug

Each of the experimental challenge drugs were administered intranasally to all participants in random order.

Trial Locations (1)

10032

New York State Psychiatric Institute and Columbia University, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Indivior Inc.

INDUSTRY

lead

New York State Psychiatric Institute

OTHER

NCT01760473 - Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone | Biotech Hunter | Biotech Hunter